1,25-DIHYDROXYCHOLECALCIFEROL IN HYPOPARATHYROIDISM
- 1 January 1977
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 309 (8002), 55-59
- https://doi.org/10.1016/s0140-6736(77)91077-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- METABOLIC FATE OF ADMINISTERED 1,25-DIHYDROXYCHOLECALCIFEROL IN CONTROLS AND IN PATIENTS WITH HYPOPARATHYROIDISMThe Lancet, 1976
- Effects of 1α-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidismMetabolism, 1975
- Treatment of Hypoparathyroidism and Pseudohypoparathyroidism with Metabolites of Vitamin D: Evidence for Impaired Conversion of 25-Hydroxyvitamin D to 1α,25-Dihydroxyvitamin DNew England Journal of Medicine, 1975
- 1,25-DIHYDROXYCHOLECALCIFEROL AND 1α-HYDROXYCHOLECALCIFEROL IN HYPOPARATHYROIDISMThe Lancet, 1974
- The Acute Renal Tubular Effects of 1,25-DihydroxycholecalciferolExperimental Biology and Medicine, 1972
- Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysisClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- Control of 25-Hydroxycholecalciferol Metabolism by Parathyroid GlandsProceedings of the National Academy of Sciences, 1972
- 21 The Measurement and the Meaning of Urinary CalciumPublished by Wolters Kluwer Health ,1967
- Effects of Serum Calcium Level and Parathyroid Extracts on Phosphate and Calcium Excretion in Hypoparathyroid Patients*Journal of Clinical Investigation, 1965
- METABOLIC STUDIES OF RENAL OSTEODYSTROPHYMedicine, 1962